BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 26854930)

  • 1. Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma.
    Jacquelot N; Enot DP; Flament C; Vimond N; Blattner C; Pitt JM; Yamazaki T; Roberti MP; Daillère R; Vétizou M; Poirier-Colame V; Semeraro M; Caignard A; Slingluff CL; Sallusto F; Rusakiewicz S; Weide B; Marabelle A; Kohrt H; Dalle S; Cavalcanti A; Kroemer G; Di Giacomo AM; Maio M; Wong P; Yuan J; Wolchok J; Umansky V; Eggermont A; Zitvogel L
    J Clin Invest; 2016 Mar; 126(3):921-37. PubMed ID: 26854930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of PD-L1 Expression and Associated T-cell Infiltrates in Metastatic Melanoma Samples from Variable Anatomic Sites.
    Kluger HM; Zito CR; Barr ML; Baine MK; Chiang VL; Sznol M; Rimm DL; Chen L; Jilaveanu LB
    Clin Cancer Res; 2015 Jul; 21(13):3052-60. PubMed ID: 25788491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients.
    Wistuba-Hamprecht K; Martens A; Heubach F; Romano E; Geukes Foppen M; Yuan J; Postow M; Wong P; Mallardo D; Schilling B; Di Giacomo AM; Khammari A; Dreno B; Maio M; Schadendorf D; Ascierto PA; Wolchok JD; Blank CU; Garbe C; Pawelec G; Weide B
    Eur J Cancer; 2017 Mar; 73():61-70. PubMed ID: 28167454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemokine receptors expression on T cells: contribution to diagnosis of melanoma metastasis dissemination status].
    Jacquelot N; Enot DP; Flament C; Dalle S; Zitvogel L
    Med Sci (Paris); 2016 8-9; 32(8-9):690-2. PubMed ID: 27615171
    [No Abstract]   [Full Text] [Related]  

  • 5. Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7.
    Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Lenz J; Speuser P; Erdmann S; Abuzahra F; Bowman E; Roszkiewicz J; Bieber T; Tüting T
    Br J Dermatol; 2005 Feb; 152(2):258-64. PubMed ID: 15727636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer-infiltrating T lymphocytes display a distinct chemokine receptor expression profile.
    Löfroos AB; Kadivar M; Resic Lindehammer S; Marsal J
    Eur J Med Res; 2017 Oct; 22(1):40. PubMed ID: 29020986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of B-cell density in cutaneous melanoma.
    Ladányi A; Kiss J; Mohos A; Somlai B; Liszkay G; Gilde K; Fejös Z; Gaudi I; Dobos J; Tímár J
    Cancer Immunol Immunother; 2011 Dec; 60(12):1729-38. PubMed ID: 21779876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paucity of tumor-infiltrating lymphocytes is an unfavorable prognosticator and predicts lymph node metastases in cutaneous melanoma patients.
    Donizy P; Kaczorowski M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
    Anticancer Res; 2015 Jan; 35(1):351-8. PubMed ID: 25550571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression.
    van Houdt IS; Sluijter BJ; Moesbergen LM; Vos WM; de Gruijl TD; Molenkamp BG; van den Eertwegh AJ; Hooijberg E; van Leeuwen PA; Meijer CJ; Oudejans JJ
    Int J Cancer; 2008 Aug; 123(3):609-15. PubMed ID: 18498132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors.
    Monteagudo C; Martin JM; Jorda E; Llombart-Bosch A
    J Clin Pathol; 2007 Jun; 60(6):596-9. PubMed ID: 16522748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease.
    Mullins IM; Slingluff CL; Lee JK; Garbee CF; Shu J; Anderson SG; Mayer ME; Knaus WA; Mullins DW
    Cancer Res; 2004 Nov; 64(21):7697-701. PubMed ID: 15520172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells in the human metastatic melanoma microenvironment express site-specific homing receptors and retention integrins.
    Salerno EP; Olson WC; McSkimming C; Shea S; Slingluff CL
    Int J Cancer; 2014 Feb; 134(3):563-74. PubMed ID: 23873187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective accumulation of mature DC-Lamp+ dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma.
    Movassagh M; Spatz A; Davoust J; Lebecque S; Romero P; Pittet M; Rimoldi D; Liénard D; Gugerli O; Ferradini L; Robert C; Avril MF; Zitvogel L; Angevin E
    Cancer Res; 2004 Mar; 64(6):2192-8. PubMed ID: 15026362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma.
    Ladányi A; Somlai B; Gilde K; Fejös Z; Gaudi I; Tímár J
    Clin Cancer Res; 2004 Jan; 10(2):521-30. PubMed ID: 14760073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel prognostic biomarker LCP2 correlates with metastatic melanoma-infiltrating CD8
    Wang Z; Peng M
    Sci Rep; 2021 Apr; 11(1):9164. PubMed ID: 33911146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the chemokine receptors CXCR4, CCR7, CCR9, and CCR10 in human primary cutaneous melanoma: a potential prognostic value for CCR7 and CCR10?
    Kühnelt-Leddihn L; Müller H; Eisendle K; Zelger B; Weinlich G
    Arch Dermatol Res; 2012 Apr; 304(3):185-93. PubMed ID: 22350183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of CCL27 and CCR10 expression in melanoma progression and immune escape.
    Simonetti O; Goteri G; Lucarini G; Filosa A; Pieramici T; Rubini C; Biagini G; Offidani A
    Eur J Cancer; 2006 May; 42(8):1181-7. PubMed ID: 16644201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8⁺ tumor-infiltrating lymphocytes at primary sites as a possible prognostic factor of cutaneous angiosarcoma.
    Fujii H; Arakawa A; Utsumi D; Sumiyoshi S; Yamamoto Y; Kitoh A; Ono M; Matsumura Y; Kato M; Konishi K; Shiga T; Sano S; Sakaguchi S; Miyagawa-Hayashino A; Takahashi K; Uezato H; Miyachi Y; Tanioka M
    Int J Cancer; 2014 May; 134(10):2393-402. PubMed ID: 24243586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like Disease.
    Clancy-Thompson E; Perekslis TJ; Croteau W; Alexander MP; Chabanet TB; Turk MJ; Huang YH; Mullins DW
    Cancer Immunol Res; 2015 Aug; 3(8):956-67. PubMed ID: 26048575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer.
    Mao Y; Li W; Chen K; Xie Y; Liu Q; Yao M; Duan W; Zhou X; Liang R; Tao M
    Oncotarget; 2015 Feb; 6(5):3452-61. PubMed ID: 25609202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.